Drug Shortage Report for PROPOFOL

Last updated on 2020-04-25 History
Report ID 109301
Drug Identification Number 02468336
Brand name PROPOFOL
Common or Proper name Propofol Injectable Emulsion, BP 1% W/V
Company Name BAXTER CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) PROPOFOL
Strength(s) 10MG
Dosage form(s) EMULSION
Route of administration INTRAVENOUS
Packaging size 100mL Vials (AIN00003)
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-03-24
Actual start date 2020-03-24
Estimated end date 2020-04-24
Actual end date 2020-04-24
Shortage status Resolved
Updated date 2020-04-25
Company comments Product Released. Will remain on allocation.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-03-24 English Compare
v2 2020-03-24 French Compare
v3 2020-03-24 English Compare
v4 2020-03-24 French Compare
v5 2020-03-25 English Compare
v6 2020-04-15 English Compare
v7 2020-04-15 French Compare
v8 2020-04-20 English Compare
v9 2020-04-20 French Compare
v10 2020-04-24 English Compare
v11 2020-04-24 English Compare
v12 2020-04-24 French Compare
v13 2020-04-25 English Compare

Showing 1 to 13 of 13